Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - ONCOVISTA INNOVATIVE THERAPIES, INC | v231684_10q.htm |
| EX-31.1 - EXHIBIT 31.1 - ONCOVISTA INNOVATIVE THERAPIES, INC | v231684_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - ONCOVISTA INNOVATIVE THERAPIES, INC | v231684_ex31-2.htm |
| EXCEL - IDEA: XBRL DOCUMENT - ONCOVISTA INNOVATIVE THERAPIES, INC | Financial_Report.xls |
EX-32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of OncoVista Innovative Therapies, Inc. (the “Company”) for the period ended June 30, 2011 filed with the Securities and Exchange Commission (the “Report”), I, Alexander L. Weis, Chief Executive Officer, President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and consolidated results of operations of the Company for the periods presented.
|
Dated: August 11, 2011
|
||
|
By:
|
/s/ Alexander L. Weis
|
|
|
Alexander L. Weis, Ph.D.
|
||
|
Chief Executive Officer, President and Chief
|
||
|
Financial Officer
|
||
This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.